AZTA Azenta, Inc.
XNAS 36.23 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
AZTA
$36.23
—
Key stats
$36.23
- 52-Week Range
- $15.93 – $46.41
- YTD
- +8.52%
- IV Rank (30D)
- 24.82
- Straddle Price
- $5.33
- P/C Vol Ratio
- 0.14
- Market Cap
- $1.6B
- Open
- $36.66
- Day Range
- $36.22 – $37.23
- Volume
- 95,054
- Prev Close
- $36.76
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.20 |
| Cost of Equity (CAPM) | 11.77% (VRP-adj) |
| WACC | 11.75% |
| Volatility Risk Premium | +13.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +0.6% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.01 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | -8.1% |
| Book / Price | 92.1% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 43.8% |
| FCF Margin (TTM) | 1.7% |
| Debt / Equity | 0.00 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $34.36 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $36.37 |
| Bollinger Width / SMA20 | 65.9% (drives anchor stability) |
| Net Debt | $-0.2B |
| Market Cap | $2B |
Peers used for multiples: ACLS, ACMR, ASYS, CRCT, ERII, VECO, VELO
(SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
59%
20-Day Fair Value
≈ by Nov 20, 2026
$37.32
α +2.4%
rank 52%
conviction
95%
40-Day Fair Value
≈ by Dec 21, 2026
$37.50
α +2.9%
rank 53%
conviction
84%
60-Day Fair Value
≈ by Jan 19, 2027
$37.06
α +1.7%
rank 47%
conviction
59%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $7.24 | 29% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 31.5× · 6 peers |
| Peer EV/EBITDA | $20.04 | 9% | median 18.5× · 6 peers |
| Peer P/B | $69.73 | 11% | median 2.1× · 7 peers |
| Peer P/S | $48.20 | 11% | median 3.7× · 7 peers |
| Market Anchor (SMA50) | $34.36 | 40% | stability 71% (BB-width) |
| Options Expected (B-L 30d) | $36.90 | 0% | 9 strikes · skew +0.24 |
As of 2026-10-22 · updated
Related
About
- Industry (SIC)
- SPECIAL INDUSTRY MACHINERY, NEC (3559) · industry map
- Exchange
- XNAS
- Market Cap
- $1.6B
- Employees
- 2,900
- List Date
- 1995-02-01
- CIK
- 0000933974
- Next Earnings
- 2026-11-20 (Pre-Market)
- Headquarters
- Burlington, MA
- Homepage
- https://www.azenta.com
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomi…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -18.76% | -5.16% | 0.52% | 8.01% | 16.44% | 0.21% |
| Feb | -- | 2.27% | -24.55% | -1.48% | -16.26% | -28.11% | -13.63% |
| Mar | -- | -3.65% | 2.06% | -10.43% | -15.74% | -18.23% | -9.20% |
| Apr | -- | -11.69% | -2.20% | -11.14% | -22.80% | 16.01% | -6.36% |
| May | -- | 2.00% | -0.87% | -3.05% | 1.87% | -8.15% | -1.64% |
| Jun | -- | -3.75% | 7.24% | 3.28% | 15.58% | 10.05% | 6.48% |
| Jul | -- | -3.68% | 2.02% | 22.04% | 2.96% | 6.67% | 6.00% |
| Aug | -- | -22.13% | 22.35% | -17.27% | -5.57% | 9.27% | -2.67% |
| Sep | -- | -17.29% | -11.15% | 1.15% | -4.77% | 10.52% | -4.31% |
| Oct | -- | -0.22% | -8.68% | -13.49% | -4.37% | 5.67%* | -4.22% |
| Nov | -- | 31.89% | 24.35% | 12.11% | 15.72% | -- | 21.02% |
| Dec | -8.83% | -5.84% | 12.39% | 5.91% | -4.59% | -- | -0.19% |
| Total | -8.83% | -46.65% | 7.47% | -17.21% | -32.28% | 9.26% | -14.71% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $36.48
SMA 50: $34.42
SMA 200: $28.34
Current: $36.40
EMA 12: $36.25
EMA 26: $35.64
MACD: 0.6051 | Signal: -0.2857
BULLISH
ADX (14): 28.06
TREND
+DI: 29.60
−DI: 19.40
Momentum Oscillators
RSI (14): 53.01
NEUTRAL
Stoch %K: 24.41
Stoch %D: 19.61
Williams %R: -74.81
Volume & Volatility
BB Upper: $40.72
BB Lower: $32.23
NEUTRAL
OBV: 6,221,388
Vol SMA 20: 1,211,097
Vol ROC: -92.73%
ATR: $2.09
True Range: $0.98
HV 20: 80.1%
HV 30: 66.6%
HV 60: 62.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary BULLISH (Confidence Level: 6/10)
Key drivers:
- Strong technical momentum signals
- Bullish MACD signal and RSI in overbought territory
- Beta indicates high volatility, but IV premium suggests implied volatility is reasonable
Primary risks:
- Negative news sentiment impact from recent headlines
- High beta and volatility levels
Investment thesis: AZTA's strong technical momentum and bullish MACD signal indicate a possible short-term uptrend. However, the negative news sentiment and high beta/ volatility levels pose significant risks.
Recent news sentiment impact: The recent news headlines are predominantly negative, with five articles discussing securities fraud investigations and lawsuits against AZTA. This sentiment is likely to have a bearish impact on the stock price.
Technical Analysis Trend Direction:
- Short-term: Uptrend (1-4 weeks)
- Medium-term: Bullish momentum (1-3 months)
- Long-term: Uptrend (3-12 months)
Support/Resistance Levels: Upper Bollinger Band ($32.99) and the recent highs around $33.50 serve as resistance.
Momentum Signals:
- RSI: 71.29 (overbought)
- MACD: Bullish signal with a reading of 1.90
- Bollinger Bands: Overbought
Volume Analysis: Volume SMA 20: 630256.90, indicating increasing volume interest in the stock.
News & Sentiment Analysis Recent Headlines Summary: The five recent news headlines are predominantly negative, discussing securities fraud investigations and lawsuits against AZTA.
Sentiment Assessment: Negative sentiment dominates, with a score of -5/10 (very bearish).
Catalyst Identification: No immediate catalysts identified. However, the earnings announcement could be a potential catalyst for future price movements.
Market Narrative: The market narrative is driven by negative news sentiment and high volatility, which may lead to increased risk aversion and downward pressure on the stock price.
Risk & Volatility Assessment Risk Assessment:
- Beta: 1.52 (high risk)
- Volatility Regime: High
Options Market Signals:
- IV rank: Low
- Put/Call Volume Ratio: 0.00 (bullish sentiment)
Downside Protection: Support levels include the recent lows around $28.50 and the lower Bollinger Band ($24.15).
Market Context & Positioning Sector Performance: AZTA's sector, Technology, is performing relatively well.
Institutional Activity: Volume patterns suggest institutional interest in the stock.
Correlation Analysis: The stock has a moderate correlation with the market (R-squared: 0.32).
Relative Valuation: Position within trading range, potentially setting up for a breakout or breakdown.
Key Levels & Action Items Critical Price Levels:
- Resistance: $32.99 (upper Bollinger Band) and recent highs around $33.50
- Support: Recent lows around $28.50 and the lower Bollinger Band ($24.15)
Breakout/Breakdown Levels: Technical levels that could trigger significant moves include:
- Upper Bollinger Band at $32.99 (resistance)
- Lower Bollinger Band at $24.15 (support)
Time-Sensitive Catalysts: Earnings announcement (no specific date available).
Risk Management: Stop-loss levels and position sizing considerations are crucial due to the high volatility and negative news sentiment.
Note: This analysis focuses on providing a comprehensive report, highlighting both bullish and bearish cases, and assessing the data quality. The confidence level is 6/10, indicating some uncertainty in the short-term direction of the stock price.
Generated
News
All AZTA news →
Earnings History
13 of 17 under expected move
Avg Expected Move
12.28%
Avg Actual Move
7.03%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2022-07-13 | Pre-Market | 12.75% | 1.01% | 0.08x | Within |
| 2022-11-14 | Pre-Market | 11.57% | 4.94% | 0.43x | Within |
| 2023-02-08 | Pre-Market | 11.90% | 3.05% | 0.26x | Within |
| 2023-05-09 | Pre-Market | 10.85% | 1.08% | 0.10x | Within |
| 2023-08-08 | Pre-Market | 10.61% | 1.20% | 0.11x | Within |
| 2023-11-13 | Pre-Market | 14.73% | 0.59% | 0.04x | Within |
| 2024-02-07 | Pre-Market | 10.54% | 2.50% | 0.24x | Within |
| 2024-05-08 | Pre-Market | 12.48% | 1.92% | 0.15x | Within |
| 2024-08-06 | After-Close | 11.40% | 8.93% | 0.78x | Within |
| 2024-11-12 | After-Close | 13.37% | 3.22% | 0.24x | Within |
| 2025-02-05 | Pre-Market | 10.92% | 3.44% | 0.32x | Within |
| 2025-05-07 | Pre-Market | 13.18% | 0.63% | 0.05x | Within |
| 2025-08-05 | Pre-Market | 15.35% | 17.00% | 1.11x | Exceeded |
| 2025-11-21 | Pre-Market | 8.25% | 16.30% | 1.98x | Exceeded |
| 2026-02-04 | Pre-Market | 12.73% | 22.81% | 1.79x | Exceeded |
| 2026-05-06 | Pre-Market | 12.09% | 25.31% | 2.09x | Exceeded |
| 2026-08-04 | After-Close | 16.01% | 5.61% | 0.35x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
AZTA Options Activity & IV Rank
AZTA IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 63.8%
7-DTE IV: —
Expected Move: $5.33
7-DTE Move: $5.33
Days to Exp: 29 (2026-11-20)
Options Flow
Call Volume: 14
Put Volume: 2
P/C Volume: 0.143
BULLISH
Call OI: 422
Put OI: 9
P/C OI: 0.021
Total OI: 431
ATM Options Pricing
ATM Call: $3.90
ATM Put: $1.43
Call %: 10.8%
Put %: 3.9%
Chain Summary
Chain Volume: 2,153
Chain OI: 3,392
Last Updated: 10/22/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 73rd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
73%
vs own history
GEX tilt
+1.00
OI-weighted, today
Vanna tilt
+0.79
δ-sensitivity to IV
Charm tilt
-0.86
δ-decay vs time
Vanna tilt +0.79: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.86: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 5 ATM contracts, 1k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
ATM 63.4% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)24.8LowOct 22
Straddle Price (30 DTE)$5.33Oct 22
Beta Analysis
Risk Metrics
Beta: 1.4449
Alpha: 14.50%
Correlation: 0.2912
R-Squared: 8.5%
Stock Volatility: 63.3%
Market Volatility: 12.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own AZTA
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $15.2M | #1303 of 6285 | +8.7% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $4.2M | #2166 of 3716 | +150.1% | 13F | |
| Point72 Hedge fund Steve Cohen | $1.7M | #1331 of 1945 | new | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $20K | #3737 of 4729 | -58.7% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
AZTA Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 45,927,750 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
4 filers$7.10M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $4.21M | 59.27% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $2.34M | 32.97% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $489.98K | 6.90% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $61.25K | 0.86% | 2026-06-30 |
7 filers$17.08M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wells Fargo & Company Custodian | $4.61M | 27.02% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $4.32M | 25.32% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $4.01M | 23.46% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $2.20M | 12.91% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $1.17M | 6.84% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $750.29K | 4.39% | 2026-06-30 |
| 7 | GROUP ONE TRADING LLC Custodian | $7.66K | 0.04% | 2026-06-30 |
AZTA Insider Trading (Form 4)
Latest: 2026-09-23Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Martin D Madaus | Interim CEO | Tax (F) | −1,456 | $34.28 | -$49.9K | EDGAR |
| 2026-09-16 | Ephraim Starr | SVP, Gen Counsel & Secretary | Award (A) | +15,272 | — | EDGAR | |
| 2026-09-16 | Olga Pirogova | SVP and CHRO | Award (A) | +15,272 | — | EDGAR | |
| 2026-09-16 | Lawrence Y. Lin | EVP, CFO and Treasurer | Award (A) | +30,544 | — | EDGAR | |
| 2026-09-16 | Erik J. Bello | VP Chief Accounting Officer | Award (A) | +4,586 | — | EDGAR | |
| 2026-09-16 | William E. Martin III | President Multiomics | Award (A) | +15,272 | — | EDGAR | |
| 2026-09-16 | Martin D Madaus | Interim CEO | Award (A) | +36,653 | — | EDGAR | |
| 2026-08-11 | Olga Pirogova | SVP and CHRO | Tax (F) | −1,085 | $32.04 | -$34.8K | EDGAR |
| 2026-08-04 | Ephraim Starr | SVP, Gen Counsel & Secretary | Buy (P) | +335 | $24.17 | $8.1K | EDGAR |
| 2026-05-19 | William L Cornog | Director | Buy (P) | +10,000 | $16.38 | $163.8K | EDGAR |
| 2026-05-18 | Ephraim Starr | SVP, Gen Counsel & Secretary | Tax (F) | −3,621 | $16.02 | -$58.0K | EDGAR |
| 2026-05-12 | Quentin Koffey | Director | Award (A) | +5,663 | — | EDGAR | |
| 2026-02-06 | William L Cornog | Director | — | — | — | EDGAR | |
| 2026-02-06 | Tina Susan Nova | Director | Award (A) | +5,663 | $27.85 | $157.7K | EDGAR |
| 2026-02-06 | Erica McLaughlin | Director | Award (A) | +5,663 | $27.85 | $157.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
AZTA Insider Holdings
21 insiders · @ $36.40
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Quentin Koffey | Director | 4,622,450 | $168.26M | $0 | 3 | 2026-05-12 |
| 2 | John Marotta | President and CEO | 213,193 | $7.76M | $569.6K | 10 | 2025-12-03 |
| 3 | Jason Joseph | SVP, General Counsel, Secy. | 112,564 | $4.10M | -$45.6K | 10 | 2024-11-21 |
| 4 | Lawrence Y. Lin | EVP, CFO and Treasurer | 110,199 | $4.01M | $69.9K | 7 | 2026-09-16 |
| 5 | Ephraim Starr | SVP, Gen Counsel & Secretary | 84,000 | $3.06M | $8.1K | 5 | 2026-09-16 |
| 6 | Olga Pirogova | SVP and CHRO | 47,225 | $1.72M | -$52.9K | 10 | 2026-09-16 |
| 7 | William L Cornog | Director | 42,750 | $1.56M | $848.7K | 9 | 2026-05-19 |
| 8 | Martin D Madaus | Interim CEO | 42,602 | $1.55M | $201.4K | 7 | 2026-09-23 |
| 9 | Ginger Zhou | SVP and GM, Multiomics | 38,755 | $1.41M | -$31.5K | 15 | 2025-11-25 |
| 10 | Robyn C Davis | Director | 33,627 | $1.22M | $0 | 5 | 2026-02-06 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
AZTA Board & Officers
As of SEC filings through Sep 23, 2026Directors 8
- Robyn C Davis · since Jun 28, 2013
- Erica McLaughlin · since Apr 3, 2020
- Frank Casal · since Nov 5, 2021
- Tina Susan Nova · since Feb 3, 2023
- John Marotta · since Sep 9, 2024
- Quentin Koffey · since Nov 1, 2024
- William L Cornog · since Nov 4, 2024
- Dipal Doshi · since Jan 31, 2025
Officers 7
- Martin D Madaus · Interim CEO · listed since Sep 2026
- William E. Martin III · President Multiomics · since Apr 6, 2026
- Lawrence Y. Lin · EVP, CFO and Treasurer · listed since Sep 2026
- Erik J. Bello · VP Chief Accounting Officer · since Aug 31, 2026
- Ephraim Starr · SVP, Gen Counsel & Secretary · since May 15, 2025
- Olga Pirogova · SVP and CHRO · since Nov 10, 2023
- Ginger Zhou · SVP and GM, Multiomics · listed since Aug 2025
Changes in the last 10 years (53)
| Sep 16, 2026 | Martin D Madaus no longer listed as a director in SEC filings |
| Sep 16, 2026 | Martin D Madaus first listed as Interim CEO in an SEC filing |
| Sep 16, 2026 | Lawrence Y. Lin first listed as EVP, CFO and Treasurer in an SEC filing |
| Aug 31, 2026 | Erik J. Bello became VP Chief Accounting Officer |
| Aug 22, 2026 | The company announced the departure of John Marotta as President and CEO in an SEC filing |
| Apr 6, 2026 | William E. Martin III became President Multiomics |
| Jan 29, 2026 | The company announced the departure of Alan J Malus from the board in an SEC filing |
| Nov 14, 2025 | Lawrence Y. Lin reported in an SEC filing no longer being EVP, CFO and Treasurer |
| Aug 13, 2025 | Ginger Zhou listed as SVP and GM, Multiomics (previously SVP and General Manager, Genom) in SEC filings |
| Jun 27, 2025 | The company announced the departure of Violetta Hughes as VP, Chief Accounting Officer in an SEC filing |
| May 15, 2025 | Ephraim Starr became SVP, Gen Counsel & Secretary |
| May 12, 2025 | The company announced the departure of Jason Joseph as SVP, General Counsel, Secy. in an SEC filing |
| Jan 31, 2025 | Dipal Doshi became a director |
| Nov 28, 2024 | Lawrence Y. Lin became EVP, CFO and Treasurer |
| Nov 12, 2024 | The company announced the departure of Herman Cueto as EVP, Chief Financial Officer in an SEC filing |
| Nov 6, 2024 | Alan J Malus became a director |
| Nov 4, 2024 | William L Cornog became a director |
| Nov 1, 2024 | Quentin Koffey became a director |
| Sep 9, 2024 | John Marotta became a director |
| Sep 9, 2024 | John Marotta became President and CEO |
| May 8, 2024 | The company announced the departure of Stephen S Schwartz from the board in an SEC filing |
| May 8, 2024 | The company announced the departure of Stephen S Schwartz as CEO in an SEC filing |
| Jan 30, 2024 | Martin D Madaus became a director |
| Jan 30, 2024 | Edward Peter Bousa became a director |
| Jan 30, 2024 | Didier Hirsch became a director |
| Jan 10, 2024 | The company announced the departure of Ellen M Zane from the board in an SEC filing |
| Nov 10, 2023 | Olga Pirogova became SVP and CHRO |
| Nov 10, 2023 | David Dong Wang became SVP & Gm, Sms |
| Oct 16, 2023 | Herman Cueto became EVP, Chief Financial Officer |
| Sep 25, 2023 | The company announced the departure of Lindon G Robertson as EVP & Chief Financial Officer in an SEC filing |
| Aug 31, 2023 | Violetta Hughes became VP, Chief Accounting Officer |
| Feb 13, 2023 | Dorothy E Puhy became a director |
| Feb 3, 2023 | Tina Susan Nova became a director |
| Nov 17, 2022 | Mitchell Coyne became SVP and GM, Life Sciences Proj |
| Nov 15, 2022 | Ginger Zhou became SVP and General Manager, Genom |
| Nov 11, 2022 | The company announced the departure of Mark S Wrighton from the board in an SEC filing |
| Nov 11, 2022 | The company announced the departure of Alfred Woollacott III from the board in an SEC filing |
| Oct 12, 2022 | The company announced the departure of Matthew McManus as EVP & Chief Operating Officer in an SEC filing |
| Feb 2, 2022 | Robin Vacha listed as SVP, GM Life Science Products (previously SVP, GM BLS-Products) in SEC filings |
| Feb 2, 2022 | Kimberly Crowley listed as SVP, Chief HR Officer (previously Chief Human Resources Officer) in SEC filings |
| Feb 1, 2022 | Vandana Sriram became VP, Finance & Corp. Controller |
| Feb 1, 2022 | The company announced the departure of David Pietrantoni as Principal Accounting Officer in an SEC filing |
| Jan 24, 2022 | Matthew McManus became EVP & Chief Operating Officer |
| Nov 5, 2021 | Frank Casal became a director |
| Aug 3, 2021 | Linda De Jesus became Chief Commercial Officer, LS |
| Aug 3, 2021 | Kimberly Crowley became Chief Human Resources Officer |
| Nov 5, 2020 | Robin Vacha became SVP, GM BLS-Products |
| Apr 3, 2020 | Erica McLaughlin became a director |
| Nov 12, 2019 | David Jarzynka listed as President, Semi Solutions (previously Sr. VP, General Manager) in SEC filings |
| Feb 21, 2019 | Jason Joseph listed as SVP, General Counsel, Secy. (previously VP, General Counsel, Secretary) in SEC filings |
| Jan 31, 2019 | John K McGillicuddy reported in an SEC filing no longer being a director |
| Nov 15, 2018 | Guojuan Liao became President, GENEWIZ |
| Sep 4, 2018 | Michael Rosenblatt became a director |
Not reported recently (19)
- David Dong Wang · Last reported as SVP & Gm, Sms in an SEC filing dated Dec 5, 2024
- Didier Hirsch · Last reported as a director in an SEC filing dated Nov 19, 2024
- Robin Vacha · Last reported as SVP, GM Life Science Products in an SEC filing dated Aug 2, 2024
- Michael Rosenblatt · Last reported as a director in an SEC filing dated Feb 13, 2024
- Edward Peter Bousa · Last reported as a director in an SEC filing dated Feb 13, 2024
- David C Gray · Last reported as Chief Strategy & New Business in an SEC filing dated Nov 20, 2023
- Joseph R Martin · Last reported as a director in an SEC filing dated Jun 7, 2023
- Krishna G. Palepu · Last reported as a director in an SEC filing dated Feb 15, 2023
- Dorothy E Puhy · Last reported as a director in an SEC filing dated Feb 15, 2023
- Kimberly Crowley · Last reported as SVP, Chief HR Officer in an SEC filing dated Feb 2, 2023
- Vandana Sriram · Last reported as VP, Finance & Corp. Controller in an SEC filing dated Feb 2, 2023
- Mitchell Coyne · Last reported as SVP and GM, Life Sciences Proj in an SEC filing dated Nov 21, 2022
- Linda De Jesus · Last reported as Chief Commercial Officer, LS in an SEC filing dated Aug 1, 2022
- David Jarzynka · Last reported as President, Semi Solutions in an SEC filing dated Nov 22, 2021
- William T. Montone · Last reported as SVP, Human Resources in an SEC filing dated Sep 29, 2021
- Guojuan Liao · Last reported as President, GENEWIZ in an SEC filing dated Nov 20, 2020
- A Clinton Allen · Last reported as a director in an SEC filing dated Sep 25, 2020
- Kirk P Pond · Last reported as a director in an SEC filing dated Dec 20, 2019
- Maurice H. Tenney · Last reported as President-Brooks Life Sciences in an SEC filing dated Feb 15, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
AZTA Proposed Insider Sales (Form 144)
Latest: 2024-08-01
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2024-08-01 | JASON JOSEPH | Officer | 1,000 | $62.0K | 2024-08-01 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-07-25 | JASON JOSEPH | Officer | 3,000 | $180.0K | 2024-07-25 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-05-20 | Hughes Violetta | Officer | 584 | $30.0K | 2024-05-20 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2024-04-01 | JASON JOSEPH | Officer | 1,000 | $60.1K | 2024-04-01 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-03-08 | JASON JOSEPH | Officer | 4,000 | $270.0K | 2024-03-08 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-03-07 | JASON JOSEPH | Officer | 9,000 | $586.0K | 2024-03-07 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-02-14 | PUHY DOROTHY E | Former Director | 3,604 | $237.9K | 2024-02-14 | Merrill Private Wealth Managemen… | — | EDGAR |
| 2024-02-08 | Joseph R. Martin Revocable Trust dtd. 01/16/2024 | Former Chairman; Trustee of Joseph R Martin Rev Tr | 5,175 | $350.5K | 2024-02-08 | UBS Financial Services Inc | — | EDGAR |
| 2023-12-05 | Vacha Robin | Officer | 5,175 | $292.9K | 2023-12-05 | Morgan Stanley Smith Barney LLCE… | — | EDGAR |
| 2023-11-17 | Gray David C | Officer | 5,179 | $254.6K | 2023-11-17 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
86 ETFs hold AZTA
25 shown · $358.82M total exposure · 0.07% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.08% | $83.9M | $103.1B | 2026-10-20 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $43.7M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.05% | $38.2M | $75.1B | 2026-10-20 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.02% | $31.0M | — | 2026-09-30 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.03% | $20.1M | — | 2026-09-30 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $15.6M | — | 2026-09-30 |
| 7 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.06% | $15.1M | — | 2026-10-20 |
| 8 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.10% | $14.0M | $13.7B | 2026-10-20 |
| 9 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.08% | $12.8M | $15.7B | 2026-10-20 |
| 10 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.04% | $12.6M | $31.4B | 2026-10-20 |
| 11 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.05% | $8.5M | — | 2026-09-30 |
| 12 | IJT iShares S&P Small-Cap 600 Growth ETF | iShares (BlackRock) | 0.10% | $7.8M | $7.6B | 2026-10-20 |
| 13 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $7.4M | — | 2026-10-20 |
| 14 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.02% | $7.0M | — | 2026-10-20 |
| 15 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.08% | $4.9M | — | 2026-09-30 |
| 16 | SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF | SPDR (State Street) | 0.10% | $4.8M | $4.6B | 2026-10-20 |
| 17 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.06% | $4.6M | $7.6B | 2026-10-20 |
| 18 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $4.5M | — | 2026-05-31 |
| 19 | VHT Vanguard Health Care ETF | Vanguard | 0.02% | $4.4M | — | 2026-09-30 |
| 20 | USVM VictoryShares US Small Mid Cap Value Momentum ETF | Nport | 0.20% | $3.6M | — | 2026-06-30 |
| 21 | KOMP State Street® SPDR® S&P Kensho New Economies Composite ETF | SPDR (State Street) | 0.12% | $3.1M | $2.5B | 2026-10-20 |
| 22 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.06% | $2.9M | $4.7B | 2026-10-20 |
| 23 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.03% | $2.9M | — | 2026-05-31 |
| 24 | ESML iShares ESG Aware MSCI USA Small-Cap ETF | iShares (BlackRock) | 0.10% | $2.7M | $2.7B | 2026-10-20 |
| 25 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.10% | $2.7M | — | 2026-07-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-3.87
TTM Revenue
$596.33M
TTM Net Income
$-178.20M
TTM Op. Cash Flow
$62.34M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-03-31 | $144.79M | $-160.80M | $-3.49 | $13.51M |
| Q1 '26 | 2025-12-31 | $148.64M | $-15.43M | $-0.34 | $20.85M |
| Q4 '25 | 2025-09-30 | $158.95M | $50.84M | $1.11 | $2.17M |
| Q3 '25 | 2025-06-30 | $143.94M | $-52.81M | $-1.15 | $25.81M |
| Q2 '25 | 2025-03-31 | $143.34M | $-47.66M | $-1.04 | $14.40M |
| Q1 '25 | 2024-12-31 | $147.44M | $-10.99M | $-0.25 | $29.80M |
| Q4 '24 | 2024-09-30 | $151.08M | $-5.71M | $-0.20 | $17.59M |
| Q3 '24 | 2024-06-30 | $144.29M | $-6.58M | $-0.12 | $9.78M |
| Q2 '24 | 2024-03-31 | $136.35M | $-136.88M | $-2.47 | $8.62M |
| Q1 '24 | 2023-12-31 | $141.72M | $-15.72M | $-0.28 | $13.76M |
| Q4 '23 | 2023-09-30 | $172.36M | $3.38M | $0.04 | $48.13M |
| Q3 '23 | 2023-06-30 | $165.95M | $-1.47M | $-0.02 | $16.75M |
Q2 2026 • period ending 2026-03-31 • filed 2026-05-08
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.08
P/S
2.81
EV/EBITDA
39.07
EV/Sales
2.41
ROE
-11.5%
ROA
-9.4%
Div Yield
0.00%
FCF Yield
3.73%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$1.67B
as of 2026-10-22
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
5.32M
SI % of Float
13.67%
Days to Cover
6.12
Short Vol Ratio
59.2%
Free Float
38.90M
Float %
88.8%
Short interest 2026-09-30 • Short volume 2026-10-21 • Float 2026-09-22